Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Targeting the RUNX3–miR-186-3p–DAT–IGF1R axis as a therapeutic strategy in a Parkinson’s disease model

Fig. 5

Knocking down the expression of miR-186-3p in dopaminergic neurons of PD mouse midbrain tissue can inhibit the activation of apoptosis pathways and increase the content of dopamine and its metabolites. A WB analysis for the detection the expression of P-PI3K, PI3K, P-AKT and AKT protein. B, C P-PI3K and P-AKT protein expression statistical graph. D WB analysis for the detection the expression of Cleaved caspase-3, Cytochrome c, Bax and Bcl-2 protein. E, F Protein expression statistical graph. G Dopamine peak chart. H LC–MS/MS detection of dopamine content in midbrain tissue. I Homovanillic acid peak chart. J LC–MS/MS detection of homovanillic acid content in midbrain tissue. K Tyrosine peak chart. L LC–MS/MS detection of tyrosine content in midbrain tissue. Data are presented as mean ± standard deviation. One-way ANOVA was used to compare differences among multiple groups. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page